184 related articles for article (PubMed ID: 36810892)
41. CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas.
Xu S; Li X; Tang L; Liu Z; Yang K; Cheng Q
Front Mol Biosci; 2021; 8():706949. PubMed ID: 34540893
[No Abstract] [Full Text] [Related]
42. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
[TBL] [Abstract][Full Text] [Related]
43.
Hu Z; Qu S
Front Immunol; 2021; 12():683572. PubMed ID: 34267752
[TBL] [Abstract][Full Text] [Related]
44.
Ge X; Xu M; Cheng T; Hu N; Sun P; Lu B; Wang Z; Li J
Front Immunol; 2022; 13():974346. PubMed ID: 36275718
[TBL] [Abstract][Full Text] [Related]
45. Transcriptome profile and clinical characterization of ICOS expression in gliomas.
Wang J; Shi F; Shan A
Front Oncol; 2022; 12():946967. PubMed ID: 36276141
[TBL] [Abstract][Full Text] [Related]
46. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
Li YF; Tsai WC; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375517
[TBL] [Abstract][Full Text] [Related]
47. Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma.
Xu L; Shao F; Luo T; Li Q; Tan D; Tan Y
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955624
[TBL] [Abstract][Full Text] [Related]
48. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
Jiang G; Mu J; Liu X; Peng X; Zhong F; Yuan W; Deng F; Peng X; Peng S; Zeng X
Sci Rep; 2020 Mar; 10(1):4220. PubMed ID: 32144351
[TBL] [Abstract][Full Text] [Related]
50. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124
[TBL] [Abstract][Full Text] [Related]
51. Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration.
Wu S; Miao K; Wang L; Ma Y; Wu X
Med Oncol; 2022 Jan; 39(2):27. PubMed ID: 35018510
[TBL] [Abstract][Full Text] [Related]
52. MiR-16-5p suppresses breast cancer proliferation by targeting ANLN.
Wang Z; Hu S; Li X; Liu Z; Han D; Wang Y; Wei L; Zhang G; Wang X
BMC Cancer; 2021 Nov; 21(1):1188. PubMed ID: 34743685
[TBL] [Abstract][Full Text] [Related]
53. CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma.
Jiang Y; Ji Q; Long X; Wang P; Tu Z; Zhang X; Zhu X; Huang K; Li J
Front Immunol; 2022; 13():810832. PubMed ID: 35265072
[TBL] [Abstract][Full Text] [Related]
54. Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis.
Xu Z; Chen X; Song L; Yuan F; Yan Y
Front Immunol; 2022; 13():834595. PubMed ID: 35281049
[TBL] [Abstract][Full Text] [Related]
55. Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma.
Chen L; Xiong Z; Zhao H; Teng C; Liu H; Huang Q; Wanggou S; Li X
Front Oncol; 2022; 12():889351. PubMed ID: 36033495
[TBL] [Abstract][Full Text] [Related]
56. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
[TBL] [Abstract][Full Text] [Related]
57. New prognostic biomarker
Li S; Gao P; Dai X; Ye L; Wang Z; Cheng H
Ann Transl Med; 2022 Feb; 10(4):206. PubMed ID: 35280380
[TBL] [Abstract][Full Text] [Related]
58. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
59.
Xu L; Liu Z; Wang H; Lu J; Xu J; Meng Y; Huang K; Liu B
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980973
[TBL] [Abstract][Full Text] [Related]
60. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
